SE431334B - Analogiforfarande for framstellning av racemiska eller optiskt aktiva, kondenserade pyrimidinderivat - Google Patents

Analogiforfarande for framstellning av racemiska eller optiskt aktiva, kondenserade pyrimidinderivat

Info

Publication number
SE431334B
SE431334B SE7701375A SE7701375A SE431334B SE 431334 B SE431334 B SE 431334B SE 7701375 A SE7701375 A SE 7701375A SE 7701375 A SE7701375 A SE 7701375A SE 431334 B SE431334 B SE 431334B
Authority
SE
Sweden
Prior art keywords
pyrimidide
racemic
condensed
derivatives
preparation
Prior art date
Application number
SE7701375A
Other languages
English (en)
Swedish (sv)
Other versions
SE7701375L (sv
Inventor
I Hermecz
Z Meszaros
S Virag
L Vasvari
A Horvath
J Knoll
G Sebestyen
A David
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE7701375L publication Critical patent/SE7701375L/xx
Publication of SE431334B publication Critical patent/SE431334B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7701375A 1976-02-12 1977-02-08 Analogiforfarande for framstellning av racemiska eller optiskt aktiva, kondenserade pyrimidinderivat SE431334B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1642A HU174693B (hu) 1976-02-12 1976-02-12 Sposob poluchenija kondensirovannykh proizvodnykh pirimidina

Publications (2)

Publication Number Publication Date
SE7701375L SE7701375L (sv) 1977-08-13
SE431334B true SE431334B (sv) 1984-01-30

Family

ID=10994601

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701375A SE431334B (sv) 1976-02-12 1977-02-08 Analogiforfarande for framstellning av racemiska eller optiskt aktiva, kondenserade pyrimidinderivat

Country Status (28)

Country Link
US (2) US4123533A (pl)
JP (1) JPS5297996A (pl)
AR (1) AR220675A1 (pl)
AT (1) AT357539B (pl)
AU (1) AU512470B2 (pl)
BE (1) BE851346A (pl)
BG (1) BG29723A3 (pl)
CA (1) CA1082699A (pl)
CH (1) CH637651A5 (pl)
CS (1) CS199288B2 (pl)
DD (1) DD131557A5 (pl)
DE (1) DE2705778A1 (pl)
DK (1) DK152431C (pl)
ES (1) ES455800A1 (pl)
FI (1) FI63574C (pl)
FR (1) FR2340945A1 (pl)
GB (1) GB1554370A (pl)
GR (1) GR62466B (pl)
HU (1) HU174693B (pl)
IL (1) IL51388A (pl)
IN (1) IN146173B (pl)
NL (1) NL7701461A (pl)
NO (1) NO146775C (pl)
PL (1) PL109346B1 (pl)
PT (1) PT66184B (pl)
SE (1) SE431334B (pl)
SU (1) SU969165A3 (pl)
YU (1) YU33777A (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
HU185925B (en) * 1977-12-29 1985-04-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing compounds with nitrogen bridge head
HU180439B (en) * 1977-12-29 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
HU180701B (en) * 1977-12-29 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing pyrido-/1,2-a/pyrimidines containing a carboxylic or ester group on the pirimidimering
HU178496B (en) * 1977-12-29 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity
HU184058B (en) * 1977-12-29 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new compounds with nitrogen bridge head
US4642384A (en) * 1979-03-19 1987-02-10 Riker Laboratories, Inc. Process for the preparation of derivatives of pyrrolidine and piperidine
AT370731B (de) * 1979-05-02 1983-04-25 Chinoin Gyogyszer Es Vegyeszet Verfahren zur herstellung von neuen kondensierten pyrimidin-derivaten sowie von deren optischen antipoden und salzen
HU183408B (en) * 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
AT377586B (de) 1981-06-30 1985-04-10 Erba Farmitalia Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen
ES8406476A1 (es) * 1982-04-29 1984-07-01 Erba Farmitalia Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas.
IL69274A (en) * 1982-08-05 1986-08-31 Erba Farmitalia (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
US5252572A (en) * 1988-02-03 1993-10-12 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same
EP1539762A2 (en) * 2002-06-26 2005-06-15 Bristol-Myers Squibb Company Bicyclic pyrimidinones as coagulation cascade inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3376304A (en) * 1962-03-14 1968-04-02 Mcneilab Inc 2-(r-r1-r2-methyl)-6-r3-6-r4-fulvenes
US3907798A (en) * 1966-06-15 1975-09-23 Sterling Drug Inc Preparation of 4H-pyrido{8 1,2-a{9 pyrimidin-4-ones from cyclic alkylidene 2-pyridylaminomethylenemalonates
AT286990B (de) * 1966-11-02 1971-01-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen
US3567719A (en) * 1967-05-17 1971-03-02 Eastman Kodak Co Methods for preparing dyes and novel dye intermediates
US3635956A (en) * 1968-03-01 1972-01-18 Squibb & Sons Inc Benzothiazines related compounds derivatives and salts thereof
FR2187311B1 (pl) * 1972-06-02 1975-06-20 Bouchara Emile
HU168014B (pl) * 1973-03-30 1976-02-28
US3897420A (en) * 1973-06-28 1975-07-29 Squibb & Sons Inc 2-Aminoalkyl-7-substituted-3,3a,4,5,6,7-hexahydro-3-substituted-2H-pyrazolo(4,3-c)pyridines
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
DE2427614A1 (de) * 1974-06-07 1976-01-02 Gruenenthal Chemie Neue pyrrolderivate und verfahren zu ihrer herstellung
US3898224A (en) * 1974-09-09 1975-08-05 Squibb & Sons Inc 1,6,7,8-Tetrahydro-4-oxo-4H-pyrido {8 1,2-A{9 pyrimidine-9-carboalkoxy compounds
US3965100A (en) * 1975-02-26 1976-06-22 E. R. Squibb & Sons, Inc. 2,3-Dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10(1H)-one and its derivatives
US3935197A (en) * 1975-05-16 1976-01-27 E. R. Squibb & Sons, Inc. 2-Styryl-4H-pyrido(1,2-a)pyrimidin-4-ones

Also Published As

Publication number Publication date
PT66184A (pt) 1977-03-01
DD131557A5 (de) 1978-07-05
FI63574C (fi) 1983-07-11
CH637651A5 (de) 1983-08-15
FR2340945B1 (pl) 1981-11-27
IL51388A0 (en) 1977-04-29
NL7701461A (nl) 1977-08-16
US4252807A (en) 1981-02-24
JPS5297996A (en) 1977-08-17
ES455800A1 (es) 1978-07-01
AR220675A1 (es) 1980-11-28
BE851346A (fr) 1977-05-31
BG29723A3 (en) 1981-01-15
IL51388A (en) 1981-07-31
PT66184B (pt) 1978-07-11
DE2705778C2 (pl) 1990-11-29
FI63574B (fi) 1983-03-31
DK152431C (da) 1988-08-01
NO146775C (no) 1982-12-08
YU33777A (en) 1983-02-28
SE7701375L (sv) 1977-08-13
HU174693B (hu) 1980-03-28
DE2705778A1 (de) 1977-08-18
JPS6228793B2 (pl) 1987-06-23
US4123533A (en) 1978-10-31
FI770453A (pl) 1977-08-13
PL109346B1 (en) 1980-05-31
FR2340945A1 (fr) 1977-09-09
CA1082699A (en) 1980-07-29
AU512470B2 (en) 1980-10-16
SU969165A3 (ru) 1982-10-23
IN146173B (pl) 1979-03-10
DK152431B (da) 1988-02-29
GR62466B (en) 1979-04-13
AT357539B (de) 1980-07-10
NO146775B (no) 1982-08-30
DK59177A (da) 1977-08-13
CS199288B2 (en) 1980-07-31
NO770457L (no) 1977-08-15
AU2217277A (en) 1978-08-17
ATA84277A (de) 1979-12-15
GB1554370A (en) 1979-10-17

Similar Documents

Publication Publication Date Title
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
SE431753B (sv) Analogifprfarande for framstellning av 2-piperazinyl-6,7-dimetoxikinazoliner
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO152899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater.
DK148260C (da) Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf
SE431334B (sv) Analogiforfarande for framstellning av racemiska eller optiskt aktiva, kondenserade pyrimidinderivat
DK520077A (da) Fremgangsmaade til fremstilling af 5-(hydroxysubstitueret-methhyl)-2,3-dihydrobenzofuran-2-carboxylsyrer eller salte estere eller amider deraf
DK55477A (da) Fremgangsmade til fremstilling af derivater af 1,2-dithiol
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE426833B (sv) Forfarande for framstellning av nya gona-4,9(10)-diener
SE435712B (sv) Analogiforfarande for framstellning av 1-nitro-9-dialkylaminoisoalkylaminoakridiner eller salter derav
DK55677A (da) Fremgangsmade til fremstilling af derivater af 1,2-dithiol
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
NO156086C (no) Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer.
NO147716C (no) Analogifremgangsmaate for fremstilling av antibakterielle erytromycylaminderivater.
DK152042C (da) Analogifremgangsmaader til fremstilling af n-cycloalkylmethyl-2-phenyl-aminoimidazolin-forbindelser eller syreadditionssalte deraf
DK173379A (da) Fremgangsmaade til fremstilling af 6alfa-halogen-3-keto-delta 1,4-pregnadienderivater
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
DK154970C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK147623C (da) Analogifremgangsmaade til fremstilling af azapurinderivater eller salte deraf
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
SE440500B (sv) Forfarande for framstellning av optiskt aktiva antracyklinoner

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7701375-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7701375-3

Format of ref document f/p: F